Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.
Laquinimod Phase IIa Study in Active Crohn's Disease
Multiple sclerosis and progressive resistance training: a systematic review.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™
Alerting Network Dysfunction in Early Multiple Sclerosis.
Anejaculatory infertility due to multiple sclerosis.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Pediatric multiple sclerosis.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
Novel therapies for memory cells in autoimmune diseases.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
HL-A antigens and multiple sclerosis.
Increased axonal expression of nectin-1 in multiple sclerosis plaques.

Pages